Acro Biomedical Co., Ltd. Liquidation Value
ACBM
Other
Cash & Equivalents
$4,098
As of 2025-12-31
Current Price: $0.03 (as of 2026-04-24)
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $4,098
Total Obligations: -$401,062
$-396,964
Per share: $-0.01
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $4,098
AR: $0
Total Obligations: -$401,062
$-396,964
Per share: $-0.01
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $4,098
AR: $0
Inventory: $0
Total Obligations: -$401,062
$-396,964
Per share: $-0.01
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-396,964 | $-0.01 |
| Liquid Liquidation Value | $-396,964 | $-0.01 |
| Operating Liquidation Value | $-396,964 | $-0.01 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $4,098 |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $401,062 |
| Long-term Debt | N/A |
| Op. Lease Liability | $0 |
| Finance Lease | N/A |
| Shares Outstanding | 60.0M |
Explore all 55 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $4,098 | N/A | N/A | N/A | $401,062 | N/A | $0 | N/A |
| 2025-09-30 | $4,323 | N/A | N/A | N/A | $436,942 | N/A | $0 | N/A |
| 2025-06-30 | $26 | N/A | N/A | N/A | $370,797 | N/A | $13,651 | N/A |
| 2025-03-31 | $251 | N/A | N/A | N/A | $329,081 | N/A | $18,009 | N/A |
| 2024-12-31 | $476 | N/A | N/A | N/A | $326,946 | N/A | $26,898 | N/A |
| 2024-09-30 | $701 | N/A | N/A | N/A | $317,304 | N/A | $33,375 | N/A |
| 2024-06-30 | $926 | N/A | N/A | N/A | $308,029 | N/A | $39,755 | N/A |
| 2024-03-31 | $151 | N/A | N/A | N/A | $297,780 | N/A | $43,726 | N/A |
▼ Community Notes